BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33274568)

  • 61. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients.
    Feng B; Li X; Zhang Q; Wang Y; Gu S; Yao RE; Li Z; Gao S; Chang G; Li Q; Li N; Fu L; Wang J; Wang X
    Orphanet J Rare Dis; 2023 Sep; 18(1):284. PubMed ID: 37697378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An acute encephalopathy with reduced diffusion in BRAF-associated cardio-facio-cutaneous syndrome.
    Okuzono S; Fukai R; Noda M; Miyake N; Lee S; Kaku N; Sanefuji M; Akamine S; Kanno S; Ishizaki Y; Torisu H; Kira R; Matsumoto N; Sakai Y; Ohga S
    Brain Dev; 2019 Apr; 41(4):378-381. PubMed ID: 30414707
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient.
    Choi JY; Han KM; Kim D; Lee BH; Yoo HW; Choi JH; Han YM
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autism traits in the RASopathies.
    Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
    J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A review of craniofacial and dental findings of the RASopathies.
    Cao H; Alrejaye N; Klein OD; Goodwin AF; Oberoi S
    Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):32-38. PubMed ID: 28643916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
    Bezniakow N; Gos M; Obersztyn E
    Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer-causing MAP2K1 mutation in a mosaic patient with cardio-facio-cutaneous syndrome and immunodeficiency.
    Zakharova V; Raykina E; Mersiyanova I; Deordieva E; Pershin D; Vedmedskia V; Rodina Y; Kuzmenko N; Maschan M; Shcherbina A
    Hum Mutat; 2022 Dec; 43(12):1852-1855. PubMed ID: 36054331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concurrent occurrence of an inherited 16p13.11 microduplication and a de novo 19p13.3 microdeletion involving MAP2K2 in a patient with developmental delay, distinctive facial features, and lambdoid synostosis.
    Shimojima K; Ondo Y; Matsufuji M; Sano N; Tsuru H; Oyoshi T; Higa N; Tokimura H; Arita K; Yamamoto T
    Eur J Med Genet; 2016 Nov; 59(11):559-563. PubMed ID: 27751966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
    Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene.
    Serra G; Felice S; Antona V; Di Pace MR; Giuffrè M; Piro E; Corsello G
    Ital J Pediatr; 2022 May; 48(1):65. PubMed ID: 35509048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
    Kratz CP; Franke L; Peters H; Kohlschmidt N; Kazmierczak B; Finckh U; Bier A; Eichhorn B; Blank C; Kraus C; Kohlhase J; Pauli S; Wildhardt G; Kutsche K; Auber B; Christmann A; Bachmann N; Mitter D; Cremer FW; Mayer K; Daumer-Haas C; Nevinny-Stickel-Hinzpeter C; Oeffner F; Schlüter G; Gencik M; Überlacker B; Lissewski C; Schanze I; Greene MH; Spix C; Zenker M
    Br J Cancer; 2015 Apr; 112(8):1392-7. PubMed ID: 25742478
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Severe neuroglycopenic symptoms due to nonketotic hypoglycemia in children with cardio-facio-cutaneous syndrome.
    Shiohama T; Fujii K; Kosaki R; Watanabe Y; Uchida T; Hagiwara S; Kinoshita K; Sugita K; Aoki Y; Shimojo N
    Am J Med Genet A; 2022 Dec; 188(12):3505-3509. PubMed ID: 35943247
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Brain structural changes in patients with cardio-facio-cutaneous syndrome: effects of BRAF gene mutation and epilepsy on brain development. A case-control study by quantitative magnetic resonance imaging.
    Calandrelli R; Pilato F; Panfili M; Battaglia D; Gambardella ML; Colosimo C
    Neuroradiology; 2022 Jan; 64(1):185-195. PubMed ID: 34309696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
    Niihori T; Aoki Y; Narumi Y; Neri G; Cavé H; Verloes A; Okamoto N; Hennekam RC; Gillessen-Kaesbach G; Wieczorek D; Kavamura MI; Kurosawa K; Ohashi H; Wilson L; Heron D; Bonneau D; Corona G; Kaname T; Naritomi K; Baumann C; Matsumoto N; Kato K; Kure S; Matsubara Y
    Nat Genet; 2006 Mar; 38(3):294-6. PubMed ID: 16474404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genotype and phenotype spectrum of NRAS germline variants.
    Altmüller F; Lissewski C; Bertola D; Flex E; Stark Z; Spranger S; Baynam G; Buscarilli M; Dyack S; Gillis J; Yntema HG; Pantaleoni F; van Loon RL; MacKay S; Mina K; Schanze I; Tan TY; Walsh M; White SM; Niewisch MR; García-Miñaúr S; Plaza D; Ahmadian MR; Cavé H; Tartaglia M; Zenker M
    Eur J Hum Genet; 2017 Jun; 25(7):823-831. PubMed ID: 28594414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An adult case of cardiofaciocutaneous syndrome with BRAF mutation.
    Sato S; Hida T; Okura M; Ishikawa A; Yamashita T
    Eur J Dermatol; 2017 Aug; 27(4):412-413. PubMed ID: 28524057
    [No Abstract]   [Full Text] [Related]  

  • 79. [Clinical analysis of a child with cardio-facio-cutaneous syndrome due to a de novo variant of MAP2K1 gene].
    Cao H; Tong G; Huang R; Zhou T; Zhang W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Oct; 39(10):1129-1134. PubMed ID: 36184098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
    Sarkozy A; Carta C; Moretti S; Zampino G; Digilio MC; Pantaleoni F; Scioletti AP; Esposito G; Cordeddu V; Lepri F; Petrangeli V; Dentici ML; Mancini GM; Selicorni A; Rossi C; Mazzanti L; Marino B; Ferrero GB; Silengo MC; Memo L; Stanzial F; Faravelli F; Stuppia L; Puxeddu E; Gelb BD; Dallapiccola B; Tartaglia M
    Hum Mutat; 2009 Apr; 30(4):695-702. PubMed ID: 19206169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.